Literature DB >> 27605111

Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance.

Jessica Glen1, Lefteris Floros1, Chris Day2, Rachel Pryke3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27605111     DOI: 10.1136/bmj.i4428

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  44 in total

1.  Liver stiffness assessed by transient elastography as a potential indicator of chronic kidney disease in patients with nonalcoholic fatty liver disease.

Authors:  Shaoyou Qin; Song Wang; Xu Wang; Jiangbin Wang
Journal:  J Clin Lab Anal       Date:  2018-09-21       Impact factor: 2.352

2.  Is it time for non-alcoholic fatty liver disease screening in patients with type 2 diabetes mellitus?

Authors:  Giovanni Targher
Journal:  Hepatobiliary Surg Nutr       Date:  2020-04       Impact factor: 7.293

Review 3.  Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date.

Authors:  Somaya Albhaisi; Arun J Sanyal
Journal:  Pharmaceut Med       Date:  2019-12

Review 4.  Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus.

Authors:  Giovanni Targher; Amedeo Lonardo; Christopher D Byrne
Journal:  Nat Rev Endocrinol       Date:  2017-12-29       Impact factor: 43.330

5.  Screening for Nonalcoholic Fatty Liver Disease in the Primary Care Clinic.

Authors:  Vijay Pandyarajan; Robert G Gish; Naim Alkhouri; Mazen Noureddin
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-07

Review 6.  [New aspects of nonalcoholic steatohepatitis].

Authors:  N Stefan
Journal:  Internist (Berl)       Date:  2019-02       Impact factor: 0.743

7.  Association between urine retinol-binding protein levels and nonalcoholic fatty liver disease: A cross-sectional study in Chinese population.

Authors:  Juanwen Zhang; Zeyu Liu; Xuyao Zhang; Li Zhang; Xi Jin
Journal:  J Clin Lab Anal       Date:  2017-11-30       Impact factor: 2.352

8.  Decompensated cirrhosis is the commonest presentation for NAFLD patients undergoing liver transplant assessment.

Authors:  Ahmed Hussain; Preya J Patel; Freya Rhodes; Ankur Srivastava; David Patch; William Rosenberg
Journal:  Clin Med (Lond)       Date:  2020-05       Impact factor: 2.659

9.  Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease.

Authors:  Katharina Staufer; Emina Halilbasic; Walter Spindelboeck; Magdalena Eilenberg; Gerhard Prager; Vanessa Stadlbauer; Andreas Posch; Petra Munda; Rodrig Marculescu; Barbara Obermayer-Pietsch; Judith Stift; Carolin Lackner; Michael Trauner; Rudolf E Stauber
Journal:  United European Gastroenterol J       Date:  2019-07-12       Impact factor: 4.623

Review 10.  Dietary carbohydrates and fats in nonalcoholic fatty liver disease.

Authors:  Hannele Yki-Järvinen; Panu K Luukkonen; Leanne Hodson; J Bernadette Moore
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-07-13       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.